Cargando…

Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021

Detalles Bibliográficos
Autores principales:	Mughal, Tariq I., Psaila, Bethan, DeAngelo, Daniel J., Saglio, Giuseppe, Van Etten, Richard A., Radich, Jerald P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2021
Materias:	Perspective Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252942/ https://www.ncbi.nlm.nih.gov/pubmed/33657787 http://dx.doi.org/10.3324/haematol.2020.267252

Ejemplares similares

Chronic Myeloproliferative Neoplasms: Some Remaining Challenges
por: Mughal, Tariq I., et al.
Publicado: (2018)

Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies
por: Mughal, Tariq I., et al.
Publicado: (2020)

Children and Adolescents with Chronic Myeloproliferative Neoplasms: Still an Unmet Biological and Clinical Need?
por: Mughal, Tariq I., et al.
Publicado: (2019)

Message in a platelet: decoding platelet transcriptomes in myeloproliferative neoplasms
por: Shapiro, Susan, et al.
Publicado: (2021)

Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm Biology
por: Royston, Daniel, et al.
Publicado: (2021)

The immune landscape in BCR‐ABL negative myeloproliferative neoplasms: inflammation, infections and opportunities for immunotherapy
por: Strickland, Marie, et al.
Publicado: (2021)

Novel integrative genomic tool for interrogating lithium response in bipolar disorder
por: Hunsberger, J G, et al.
Publicado: (2015)

Building a healthy mouse model ecosystem to interrogate cancer biology
por: Devlin, Ryan, et al.
Publicado: (2022)

CALR mutation characterization in myeloproliferative neoplasms
por: Bilbao-Sieyro, Cristina, et al.
Publicado: (2016)

Personal Perspectives: Having a Prostatectomy and the Role of the Cancer Specialist Nurse
por: Taylor-Robinson, Simon D, et al.
Publicado: (2020)

Role and Importance of Functional Food Packaging in Specialized Products for Vulnerable Populations: Implications for Innovation and Policy Development for Sustainability
por: Pascall, Melvin A., et al.
Publicado: (2022)

The puzzle of myeloproliferative neoplasms: novel disease-specific mutations and new proposals for diagnostic criteria
por: Kim, Hee-Jin, et al.
Publicado: (2014)

Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders
por: Naramura, Mayumi, et al.
Publicado: (2011)

New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms
por: Hasselbalch, Hans C., et al.
Publicado: (2021)

Solving the Mystery of Myelodysplasia
por: Radich, Jerald
Publicado: (2008)

Evolving insights in blood-based liquid biopsies for prostate cancer interrogation
por: Bonfil, R. Daniel, et al.
Publicado: (2023)

Computational/Experimental Interrogation of the Failing Heart—A Perspective on “Impaired Myocardial Energetics Causes Mechanical Dysfunction in Decompensated Failing Hearts”
por: Cowley, Allen W, et al.
Publicado: (2020)

Another Philadelphia story*
por: Radich, Jerald P.
Publicado: (2022)

Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectives
por: Barosi, Giovanni, et al.
Publicado: (2023)

A tale of two alleles: TP53 and transformation in MPNs
por: Brierley, Charlotte, et al.
Publicado: (2022)

Antibodies to watch in 2021
por: Kaplon, Hélène, et al.
Publicado: (2021)

Genetic basis and molecular profiling in myeloproliferative neoplasms
por: Luque Paz, Damien, et al.
Publicado: (2023)

Myeloproliferative neoplasms: From JAK2 mutations discovery to JAK2 inhibitor therapies
por: Passamonti, Francesco, et al.
Publicado: (2011)

Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib
por: Mascarenhas, J, et al.
Publicado: (2012)

From molecular interaction to acute promyelocytic leukemia: Calculating leukemogenesis and remission from endogenous molecular-cellular network
por: Yuan, Ruoshi, et al.
Publicado: (2016)

A novel assay to detect calreticulin mutations in myeloproliferative neoplasms
por: Rosso, Valentina, et al.
Publicado: (2016)

Synoptic Diagnostics of Myeloproliferative Neoplasms: Morphology and Molecular Genetics
por: Nann, Dominik, et al.
Publicado: (2021)

Interrogating Epigenome toward Personalized Approach in Cutaneous Melanoma
por: Dobre, Elena-Georgiana, et al.
Publicado: (2021)

Climate change, urban health, and the promotion of health equity
por: Fagliano, Jerald A., et al.
Publicado: (2018)

iGEM 2021: A Year in Review
por: Moon, Hannah
Publicado: (2022)

Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis
por: Radich, Jerald P., et al.
Publicado: (2023)

Genetic–pathologic characterization of myeloproliferative neoplasms
por: Kim, Yonggoo, et al.
Publicado: (2016)

Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
por: Palomo, Laura, et al.
Publicado: (2021)

Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms
por: Vanni, Daniele, et al.
Publicado: (2022)

Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms
por: Vieri, Margherita, et al.
Publicado: (2023)

The Role of PTEN in Myeloid Malignancies
por: Morotti, Alessandro, et al.
Publicado: (2015)

Bcl‐xL represents a therapeutic target in Philadelphia negative myeloproliferative neoplasms
por: Petiti, Jessica, et al.
Publicado: (2020)

Integrated genetic and pharmacologic interrogation of rare cancers
por: Hong, Andrew L., et al.
Publicado: (2016)

Perspective: Cellular and Molecular Profiling Technologies in Personalized Oncology
por: Cruz, Andrea, et al.
Publicado: (2019)

Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications
por: Merrill, Joan T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sep32f8dcvqr9va2q889rketkg